Answers are grounded in this paper and cite their sources.
Choline and methionine have been administered as therapeutic agents to patients with liver dis- ease on the basis of demonstrated beneficial ef- fects of these agents in the dietary cirrhosis of animals (1-6). The therapeutic value of such specific agents in human liver disease is difficult to assess clinically, by tests of liver functions, or by biopsy of the liver, because of the naturally oc- curring variations in the nature, severity, and course of the disease.
No takes yet. Share an insight, caveat, or question.
Gabuzda et al. (1950) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: